{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T22:02:45Z","timestamp":1784757765505,"version":"3.55.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:00:00Z","timestamp":1767139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Yingu Pharmaceutical Co., Ltd"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Common cold is one of the most prevalent illnesses affecting human health. Nasal symptoms are the most bothersome and characteristic manifestations, yet few safe and effective treatments are currently available.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>This phase 3, randomized, double-blind, placebo-controlled trial aimed to evaluate the efficacy and safety of bencycloquidium bromide (BCQB) nasal spray in nasal symptoms of common cold.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Participants with cold symptoms for \u226448\u2009h and a rhinorrhea visual analogue scale (VAS) score \u22655 were enrolled. Participants were randomized 1:1 to receive either BCQB or placebo for 4\u2009\u00b1\u20091\u2009days. Patients self-recorded VAS scores for rhinorrhea, sneezing, nasal congestion and itching daily. Efficacy and safety were assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 480 patients were randomized and treated. The area under the curve (AUC) for rhinorrhea VAS scores over treatment period was significantly lower in the BCQB group than in the placebo group (13.01\u2009\u00b1\u20097.19 vs. 16.01\u2009\u00b1\u20098.00; P\u2009&amp;lt;\u20090.001). Daily improvement in the average rhinorrhea VAS score was significantly greater in the BCQB group from day 2 through day 4 (P\u2009&amp;lt;\u20090.005). BCQB also demonstrated significant efficacy for nasal congestion (AUC: 10.90\u2009\u00b1\u20097.42 vs. 13.63\u2009\u00b1\u20098.64; P\u2009&amp;lt;\u20090.001) and sneezing (AUC: 7.84\u2009\u00b1\u20097.18 vs. 9.30\u2009\u00b1\u20098.64; P\u2009=\u20090.046). The incidence of adverse events (AEs) was similar between the two groups, and no severe AEs were reported. BCQB was well-tolerated, with no systemic anticholinergic adverse effects observed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>BCQB nasal spray is effective and safe for treating rhinorrhea, nasal congestion and sneezing associated with common cold.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>The trial was registered at chictr.org.cn (ChiCTR2500107341).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/qjmed\/hcaf331","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T12:47:13Z","timestamp":1767185233000},"page":"473-480","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety of intranasal bencycloquidium bromide in nasal symptoms of common cold: a phase 3, multicenter, randomized, double-blind, placebo-controlled trial"],"prefix":"10.1093","volume":"119","author":[{"given":"Lixiu","family":"He","sequence":"first","affiliation":[{"name":"Clinical Trial Center, West China Hospital, Sichuan University , Chengdu, Sichuan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Yang","sequence":"additional","affiliation":[{"name":"Clinical Trial Center, West China Hospital, Sichuan University , Chengdu, Sichuan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiying","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Sichuan Academy of Medical Sciences & Sichuan Provincial People\u2019s Hospital , Chengdu, Sichuan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousheng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Zibo Central Hospital , Zibo, Shandong,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Liu","sequence":"additional","affiliation":[{"name":"Clinical Trial Center, The First Affiliated Hospital of Bengbu Medical University , Bengbu, Anhui,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengling","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Bengbu Medical University , Bengbu, Anhui,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dang","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Suzhou Municipal Hospital , Suzhou, Jiangsu,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Jiangnan University , Wuxi, Jiangsu,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maofeng","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, PKU Care Luzhong Hospital , Zibo, Shandong,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Tianjin People\u2019s Hospital , Tianjin,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nali","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Luoyang Central Hospital , Luoyang, Henan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The Third Hospital of Mianyang , Mianyang, Sichuan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhua","family":"Ao","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University , Luzhou, Sichuan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunchao","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Heze Municipal Hospital , Heze, Shandong,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuzhuang","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The First Hospital of Hebei Medical University , Shijiazhuang, Hebei,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Shandong Provincial Qianfoshan Hospital , Jinan, Shandong,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufeng","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, First Hospital of Qinhuangdao , Qinhuangdao, Hebei,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2241-2474","authenticated-orcid":false,"given":"Chuntao","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University , Chengdu, Sichuan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,12,31]]},"reference":[{"key":"2026072217471604400_hcaf331-B1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(03)12162-9","article-title":"The common cold","volume":"361","author":"Heikkinen","year":"2003","journal-title":"Lancet"},{"key":"2026072217471604400_hcaf331-B2","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1398-9995.2009.02269.x","article-title":"Allergic rhinitis and the common cold\u2014high cost to society","volume":"65","author":"Hellgren","year":"2010","journal-title":"Allergy"},{"key":"2026072217471604400_hcaf331-B3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12985-024-02524-6","article-title":"Clinical symptoms, comorbidities and health outcomes among outpatients infected with the common cold coronaviruses versus influenza virus","volume":"21","author":"Iyadorai","year":"2024","journal-title":"Virol J"},{"key":"2026072217471604400_hcaf331-B4","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0095-4543(05)70355-9","article-title":"The common cold","volume":"23","author":"Kirkpatrick","year":"1996","journal-title":"Prim Care"},{"key":"2026072217471604400_hcaf331-B5","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0091-6749(95)70218-0","article-title":"The common cold: current therapy and natural history","volume":"95","author":"Spector","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"2026072217471604400_hcaf331-B6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0002-9343(01)01059-2","article-title":"Clinical significance and pathogenesis of viral respiratory infections","volume":"112","author":"Gwaltney","year":"2002","journal-title":"Am J Med"},{"key":"2026072217471604400_hcaf331-B7","first-page":"281","article-title":"Treatment of the common cold","volume":"100","author":"DeGeorge","year":"2019","journal-title":"Am Fam Physician"},{"key":"2026072217471604400_hcaf331-B8","doi-asserted-by":"crossref","first-page":"111010","DOI":"10.1016\/j.ijporl.2021.111010","article-title":"Safety of topical administration of nasal decongestants and vasoconstrictors in paediatric nasal surgery\u2014a systematic review","volume":"153","author":"Macmillan","year":"2022","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"2026072217471604400_hcaf331-B9","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/exd.14602","article-title":"Pharmacogenomics for the efficacy and side effects of antihistamines","volume":"31","author":"Li","year":"2022","journal-title":"Exp Dermatol"},{"key":"2026072217471604400_hcaf331-B10","first-page":"CD008231","article-title":"Intranasal ipratropium bromide for the common cold","volume":"2013","author":"Albalawi","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2026072217471604400_hcaf331-B11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7326\/0003-4819-125-2-199607150-00002","article-title":"Effectiveness and safety of intranasal ipratropium bromide in common colds. A randomized, double-blind, placebo-controlled trial","volume":"125","author":"Hayden","year":"1996","journal-title":"Ann Intern Med"},{"key":"2026072217471604400_hcaf331-B12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1081-1206(10)61289-6","article-title":"Use of 0.06% ipratropium bromide nasal spray in children aged 2 to 5 years with rhinorrhea due to a common cold or allergies","volume":"94","author":"Kim","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2026072217471604400_hcaf331-B13","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jchromb.2009.02.027","article-title":"Solid phase extraction and liquid chromatography\u2013electrospray ionization\u2013mass spectrometry for the determination of bencycloquidium bromide in human plasma","volume":"877","author":"Zhou","year":"2009","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"2026072217471604400_hcaf331-B14","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ejphar.2011.01.017","article-title":"Characterization of bencycloquidium bromide, a novel muscarinic M(3) receptor antagonist in guinea pig airways","volume":"655","author":"Jiang","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"2026072217471604400_hcaf331-B15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2165\/11599330-000000000-00000","article-title":"Pharmacokinetics, safety and tolerability of bencycloquidium bromide, a novel selective muscarinic M1\/M3 receptor antagonist, after single and multiple intranasal doses in healthy Chinese subjects: an open-label, single-center, first-in-human study","volume":"12","author":"Sun","year":"2012","journal-title":"Drugs R D"},{"key":"2026072217471604400_hcaf331-B16","doi-asserted-by":"crossref","first-page":"105646","DOI":"10.1016\/j.ejps.2020.105646","article-title":"Safety, tolerability and pharmacokinetics of bencycloquidium bromide, a novel inhaled anticholinergic bronchodilator, in healthy subjects: results from phase I studies","volume":"157","author":"Luo","year":"2021","journal-title":"Eur J Pharm Sci"},{"key":"2026072217471604400_hcaf331-B17","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1007\/s00405-020-06183-5","article-title":"Bencycloquidium bromide nasal spray is effective and safe for persistent allergic rhinitis: a phase III, multicenter, randomized, double-blinded, placebo-controlled clinical trial","volume":"277","author":"Jiang","year":"2020","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"2026072217471604400_hcaf331-B18","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jaip.2024.12.035","article-title":"A randomized comparison of bencycloquidium bromide, mometasone furoate, and a combination for persistent allergic rhinitis","volume":"13","author":"Li","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026072217471604400_hcaf331-B19","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4193\/Rhino.11.152","article-title":"Up-date on neuro-immune mechanisms involved in allergic and non-allergic rhinitis","volume":"50","author":"Van Gerven","year":"2012","journal-title":"Rhinology"},{"key":"2026072217471604400_hcaf331-B20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejphar.2007.12.029","article-title":"Acetylcholine mediates the release of IL-8 in human bronchial epithelial cells by a NFkB\/ERK-dependent mechanism","volume":"582","author":"Profita","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"2026072217471604400_hcaf331-B21","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.pupt.2012.07.003","article-title":"Muscarinic receptors on airway mesenchymal cells: novel findings for an ancient target","volume":"26","author":"Meurs","year":"2013","journal-title":"Pulm Pharmacol Ther"},{"key":"2026072217471604400_hcaf331-B22","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0091-6749(95)70219-9","article-title":"A dose\u2013response study of the efficacy and safety of ipratropium bromide nasal spray in the treatment of the common cold","volume":"95","author":"Diamond","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"2026072217471604400_hcaf331-B23","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/0091-6749(92)90126-M","article-title":"A double-blind, placebo-controlled study of the safety and efficacy of ipratropium bromide nasal spray versus placebo in patients with the common cold","volume":"90","author":"Dockhorn","year":"1992","journal-title":"J Allergy Clin Immunol"},{"key":"2026072217471604400_hcaf331-B24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00011-015-0800-6","article-title":"Bencycloquidium bromide inhibits nasal hypersecretion in a rat model of allergic rhinitis","volume":"64","author":"Long","year":"2015","journal-title":"Inflamm Res"},{"key":"2026072217471604400_hcaf331-B25","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S1081-1206(10)61847-9","article-title":"Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast","volume":"90","author":"Ratner","year":"2003","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2026072217471604400_hcaf331-B26","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1067\/mai.2001.118596","article-title":"The phosphodiesterase 4 inhibitor roflumilast is effective in the treatment of allergic rhinitis","volume":"108","author":"Schmidt","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"2026072217471604400_hcaf331-B27","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/alr.21491","article-title":"Comparing the effects of ketotifen fumarate eye drops and ketotifen oral pills on symptom severity and quality of life in patients with allergic rhinitis: a double-blind randomized clinical trial","volume":"5","author":"Akhavan","year":"2015","journal-title":"Int Forum Allergy Rhinol"},{"key":"2026072217471604400_hcaf331-B28","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/sj.bjp.0702573","article-title":"Pharmacological characterization of the muscarinic receptor antagonist, glycopyrrolate, in human and guinea-pig airways","volume":"127","author":"Haddad","year":"1999","journal-title":"British J Pharmacology"},{"key":"2026072217471604400_hcaf331-B29","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.2500\/ajra.2011.25.3604","article-title":"M1 and M3 muscarinic receptors mediate relaxation and contraction in canine nasal veins","volume":"25","author":"Lung","year":"2011","journal-title":"Am J Rhinol Allergy"},{"key":"2026072217471604400_hcaf331-B30","first-page":"229","article-title":"Role of the muscarinic M2 receptor in human nasal mucosa","volume":"45","author":"Sheahan","year":"2007","journal-title":"Rhinology"},{"key":"2026072217471604400_hcaf331-B31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0954-6111(08)80001-7","article-title":"Nasal pathophysiology","volume":"84","author":"Widdicombe","year":"1990","journal-title":"Respir Med"},{"key":"2026072217471604400_hcaf331-B32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4414\/smw.2009.12468","article-title":"Pathophysiology of itching and sneezing in allergic rhinitis","volume":"139","author":"Pfaar","year":"2009","journal-title":"Swiss Med Wkly"},{"key":"2026072217471604400_hcaf331-B33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11882-020-00947-z","article-title":"Itch in organs beyond the skin","volume":"20","author":"Golpanian","year":"2020","journal-title":"Curr Allergy Asthma Rep"},{"key":"2026072217471604400_hcaf331-B34","first-page":"CD004976","article-title":"Oral antihistamine\u2013decongestant\u2013analgesic combinations for the common cold","volume":"1","author":"De Sutter","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"2026072217471604400_hcaf331-B35","first-page":"CD006821","article-title":"Saline nasal irrigation for acute upper respiratory tract infections","volume":"2015","author":"King","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2026072217471604400_hcaf331-B36","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1370\/afm.1250","article-title":"Placebo effects and the common cold: a randomized controlled trial","volume":"9","author":"Barrett","year":"2011","journal-title":"Ann Fam Med"}],"container-title":["QJM: An International Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/qjmed\/advance-article-pdf\/doi\/10.1093\/qjmed\/hcaf331\/66185565\/hcaf331.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/qjmed\/article-pdf\/119\/6\/473\/66185565\/hcaf331.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/qjmed\/article-pdf\/119\/6\/473\/66185565\/hcaf331.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T21:47:29Z","timestamp":1784756849000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/qjmed\/article\/119\/6\/473\/8407916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,31]]},"references-count":36,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12,31]]},"published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/qjmed\/hcaf331","relation":{},"ISSN":["1460-2725","1460-2393"],"issn-type":[{"value":"1460-2725","type":"print"},{"value":"1460-2393","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2025,12,31]]}}}